A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours.

Russell, Matthew R; Graham, Ciaren; D'Amato, Alfonsina; Gentry-Maharaj, Aleksandra; Ryan, Andy; Kalsi, Jatinderpal K; Ainley, Carol; Whetton, Anthony D; Menon, Usha; Jacobs, Ian; Graham, Robert L J

Russell, Matthew R; Graham, Ciaren; D'Amato, Alfonsina; Gentry-Maharaj, Aleksandra; Ryan, Andy; Kalsi, Jatinderpal K; Ainley, Carol; Whetton, Anthony D; Menon, Usha; Jacobs, Ian; Graham, Robert L J.

Affiliation

Russell MR; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road Manchester, Manchester, UK.
Graham C; Centre for Biomedicine, School of Healthcare Science, Manchester Metropolitan University, Manchester, UK.
D'Amato A; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road Manchester, Manchester, UK.
Gentry-Maharaj A; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
Ryan A; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
Kalsi JK; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
Ainley C; Centre for Biomedicine, School of Healthcare Science, Manchester Metropolitan University, Manchester, UK.
Whetton AD; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road Manchester, Manchester, UK.
Menon U; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
Jacobs I; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road Manchester, Manchester, UK.
Graham RLJ; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.

Br J Cancer ; 117(5): 666-674, 2017 Aug 22.

Article de En | MEDLINE | ID: mdl-28664912

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Marqueurs biologiques tumoraux / Antigènes CA-125 / Protéine-2 de liaison aux IGF / Dépistage précoce du cancer / Phosphatidylcholine-Sterol O-Acyltransferase Type d'étude: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Limites: Female / Humans Langue: En Journal: Br J Cancer Année: 2017 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google